Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A case of latent primary biliary cirrhosis.
Tsuji K, Watanabe Y, Kouno H, Aisaka Y, Masanaga T, Ishihara H, Kamiyasu M, Nakanishi T, Chayama K, Asahara T, Coppel R, Gershwin ME. Tsuji K, et al. Among authors: aisaka y. Hepatol Res. 2004 Mar;28(3):166-169. doi: 10.1016/j.hepres.2003.09.006. Hepatol Res. 2004. PMID: 15036074
[A case of intrahepatic portosystemic shunt via portal vein aneurysm].
Takahashi S, Kitamoto M, Takaishi H, Aisaka Y, Asada N, Tsuji K, Masanaga T, Arataki K, Nakashio R, Oobatake T, Kamiyasu M, Nakanishi T, Kajiyama G, Kawamura H. Takahashi S, et al. Among authors: aisaka y. Nihon Shokakibyo Gakkai Zasshi. 1998 Jan;95(1):46-50. Nihon Shokakibyo Gakkai Zasshi. 1998. PMID: 9483962 Japanese. No abstract available.
Predicting the response to 48-week combination therapy with peginterferon alpha-2b plus ribavirin from the estimated HCV RNA load index after negative serum change in genotype 1b hepatitis C patients.
Tsuji K, Kawakami Y, Aimitsu S, Kohno H, Aisaka Y, Kimura S, Nagata S, Ohgoshi H, Kitamoto M, Hidaka T, Kawakami H, Nakanishi T, Chayama K. Tsuji K, et al. Among authors: aisaka y. Hepatol Res. 2009 Jun;39(6):531-8. doi: 10.1111/j.1872-034X.2009.00488.x. Epub 2009 Feb 25. Hepatol Res. 2009. PMID: 19254346
Predictive value of the IFNL4 polymorphism on outcome of telaprevir, peginterferon, and ribavirin therapy for older patients with genotype 1b chronic hepatitis C.
Fujino H, Imamura M, Nagaoki Y, Kawakami Y, Abe H, Hayes CN, Kan H, Fukuhara T, Kobayashi T, Masaki K, Ono A, Nakahara T, Honda Y, Naeshiro N, Urabe A, Yokoyama S, Miyaki D, Murakami E, Kawaoka T, Hiraga N, Tsuge M, Hiramatsu A, Hyogo H, Aikata H, Takahashi S, Miki D, Ochi H, Ohishi W, Chayama K; Hiroshima Liver Study Group. Fujino H, et al. J Gastroenterol. 2014 Dec;49(12):1548-56. doi: 10.1007/s00535-013-0924-9. Epub 2013 Dec 21. J Gastroenterol. 2014. PMID: 24362944 Clinical Trial.
Effect of vitamin D supplementation on pegylated interferon/ribavirin therapy for chronic hepatitis C genotype 1b: a randomized controlled trial.
Yokoyama S, Takahashi S, Kawakami Y, Hayes CN, Kohno H, Kohno H, Tsuji K, Aisaka Y, Kira S, Yamashina K, Nonaka M, Moriya T, Kitamoto M, Aimitsu S, Nakanishi T, Kawakami H, Chayama K. Yokoyama S, et al. Among authors: aisaka y. J Viral Hepat. 2014 May;21(5):348-56. doi: 10.1111/jvh.12146. Epub 2013 Jul 30. J Viral Hepat. 2014. PMID: 24716637 Clinical Trial.
34 results